Revvity

Revvity EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Revvity (RVTY) as of Oct 8, 2026 is 25.95. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 23.81 — a change of 8.96% (higher).

EV/FCF

25.95

YoY

8.96%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Revvity is 2025 25.95 . EV/FCF (Enterprise Value to Free Cash Flow) of Revvity was 2024 23.81 . It decreases by 8.96% higher compared to the previous year.

The Revvity EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
49.32 USD
Jan 1, 2019
45.39 USD
Jan 1, 2020
15.36 USD
Jan 1, 2021
11.67 USD
Jan 1, 2022
25.01 USD
Jan 1, 2023
1,331.18 USD
Jan 1, 2024
23.81 USD
Jan 1, 2025
25.95 USD
The Revvity EV/FCF history
YEAREV/FCFYoY
25.95+8.96%
23.81-98.21%
1,331.18+5,223.24%
25.01+114.29%
11.67-24.04%
15.36-66.15%
45.39-7.97%
49.32-3.10%
50.90+54.15%
33.02-20.19%
41.37-2.50%
42.43—
Access this data via the Eulerpool API

Revvity Stock analysis

What does Revvity do? PerkinElmer Inc is an international company headquartered in Waltham, Massachusetts, USA. It provides solutions for improving health and the environment by offering instruments, consumables, software, and services in multiple industries. The company's history began in 1937 when Perkin-Elmer (named after two partners) was founded. It initially focused on manufacturing spectrometers and other instruments for chemical analysis. During World War II, Perkin-Elmer dramatically shifted its business towards the development of rocket sighting devices and aircraft parts. After the war, it returned to producing scientific equipment and began expanding into other markets. In the 1960s, Perkin-Elmer entered the field of medical diagnostics and started developing solutions for measuring hormones and proteins. Over the following decades, the company grew through expansion and acquisitions, including the purchase of Applied Biosystems, in areas such as molecular diagnostics, chromatography, genomics, and environmental analytics. PerkinElmer's business model focuses on providing solutions for customers in various fields such as pharma and biotechnology, environment and food, diagnostics, and clinical research. This includes instruments and consumables for analyzing proteins, nucleic acids, and other chemical substances, molecular diagnostic instruments and software, imaging systems for drug screening, and computer platforms for processing large amounts of data. The offered products and services of PerkinElmer encompass a wide range of solutions. The company's chromatography division offers instruments and consumables for the separation and analysis of chemical compounds. The Environmental Health division provides solutions for the identification and monitoring of pollutants in the environment, as well as for investigating food and drugs. The Analytical Sciences service division offers a wide range of analytical services to assist customers in solving research and development challenges. Other products and services of PerkinElmer include solutions for genomic analysis, drug development and manufacturing, diagnostic systems, laboratory automation, as well as software and services for data management. PerkinElmer is also a major provider of instruments and services in the field of medical imaging. One of PerkinElmer's standout products is its solutions for DNA and RNA sequencing. Using these technologies, researchers can identify genetic information that is crucial for disease diagnosis and treatment, as well as the development of new therapies and drugs. Overall, PerkinElmer offers a broad range of offerings aimed at improving health, the environment, and quality of life. The company works closely with customers in various industries to tailor its offerings to their needs. PerkinElmer is a key provider of solutions for improving health and the environment. The company offers a wide range of products and services, including instruments and consumables for chromatography, solutions for genomic analysis, and imaging systems for drug screening. Through its close collaboration with customers in various industries, PerkinElmer uses its knowledge and technology to make the world a better place. Revvity is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Revvity stock

EV/FCF (Enterprise Value to Free Cash Flow) of Revvity is 25.95 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Revvity changed from 23.81 to 25.95, representing a 8.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Revvity since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Revvity with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Revvity

All Key Metrics — Revvity